Neuromodulation therapeutics from the hospital, directly to the home of the patient. A Paris Brain Institute company.
Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application.
Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment.
Neuromodulation, Depression, Alzheimer's, and Neurotech
Nanotechnology company specialized in research and engineering of Non-Invasive Brain Stimulation technologies for the treatment of psychiatric and neurological disorders. Applicable in pathologies such as: Parkinson's | depression | Anxiety | OCD | TAHD | Autism | Vascular Brain Event | among other.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Kamet Ventures Venture Capital and Private Equity Principals | Kamet Ventures Venture Capital and Private Equity Principals | Other 31 May 2024 | | |
MEDICALPS Business Consulting and Services | MEDICALPS Business Consulting and Services | Other 19 Jul 2024 | | |
France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 23 May 2024 | | |
Institut du Cerveau – Paris Brain Institute Startup accelerator & VC, Biotechnology Research | Institut du Cerveau – Paris Brain Institute Startup accelerator & VC, Biotechnology Research | Other 11 Mar 2024 | | |
Business France National and local authorities, Government Administration | Business France National and local authorities, Government Administration | Other 3 Aug 2024 | |